NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has aligned its chromatin immunoprecipitation-on-microarrays (ChIP-chip) with Sigma Aldrich's GenomePlex whole-genome amplification technology, and the companies will co-market the technologies together.

Researchers can use the two platforms together to study the genome for epigenetic interactions between DNA and DNA-binding proteins to find out what regions are transcriptionally active or repressed, and the mechanisms that regulate these processes, Roche said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.